Drug shortage
Bumetanide Injection · Sagent Pharmaceuticals
FDA drug shortage · Current · updated Apr 17, 2025
Key facts
| Generic name | Bumetanide Injection |
|---|---|
| Proprietary name | Bumetanide |
| Company | Sagent Pharmaceuticals |
| Presentation | Bumetanide, Injection, .25 mg/1 mL (NDC 70860-405-04) |
| Dosage form | Injection |
| Strength | .25 mg/1 mL |
| Status | Current |
| Reason for shortage | Other |
| Therapeutic category | Cardiovascular |
| Package NDCs | 70860-405-04 |
| First posted | Jan 31, 2018 |
| Last updated | Apr 17, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: